47 followers
術後ctDNA陽性で再発高リスク、陽性例のみ補助化学療法が有効。 切除されたI-III期大腸癌患者におけるctDNAの実世界モニタリングは、癌の再発と治療効果を確実に予測する。 https://t.co/WDrKFvqnBv https://t.co/Np1Pw6fwWg https://t.co/2rLhKqTTsk
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer.
Overview of attention for article published in Annals of Surgery, August 2025
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (97th percentile)
Readers on
- mendeley
- 9 Mendeley